Earnings summaries and quarterly performance for Integer Holdings.
Executive leadership at Integer Holdings.
Payman Khales
President and Chief Executive Officer
Diron Smith
Executive Vice President and Chief Financial Officer
Jim Stephens
President, Cardiac Rhythm Management & Neuromodulation
John Harris
Executive Vice President, Global Operations and Manufacturing Strategy
Lindsay Blackwood
Senior Vice President, General Counsel and Corporate Secretary
Board of directors at Integer Holdings.
Cheryl Capps
Director
Craig Maxwell
Director
Donald Spence
Director
Filippo Passerini
Director
James Hinrichs
Director
Jean Hobby
Director
Michael Coyle
Director
Pamela Bailey
Chair of the Board
Sheila Antrum
Director
Tyrone Jeffers
Director
Research analysts who have asked questions during Integer Holdings earnings calls.
Richard Newitter
Truist Securities
6 questions for ITGR
Suraj Kalia
Oppenheimer & Co. Inc.
6 questions for ITGR
Joanne Wuensch
Citigroup Inc.
5 questions for ITGR
Nathan Treybeck
Wells Fargo Securities
5 questions for ITGR
Andrew Cooper
Raymond James
4 questions for ITGR
Brett Fishbin
KeyBanc Capital Markets
4 questions for ITGR
Craig Bijou
Bank of America Securities
4 questions for ITGR
Matthew O'Brien
Piper Sandler & Co.
3 questions for ITGR
Brett Fishman
KeyBanc Capital Markets Inc.
2 questions for ITGR
Matthew O'Brien
Piper Sandler
2 questions for ITGR
Travis Steed
Bank of America
2 questions for ITGR
Kristen Stewart
CL King & Associates
1 question for ITGR
Matt O'Brien
Piper Sandler Companies
1 question for ITGR
Recent press releases and 8-K filings for ITGR.
- A class action lawsuit has been filed against Integer Holdings Corporation (ITGR) and its senior executives for securities fraud by Bleichmar Fonti & Auld LLP.
- The lawsuit alleges Integer repeatedly touted its electrophysiology (EP) sales growth and market position while overstating demand for its EP devices, which had actually fallen sharply.
- On October 23, 2025, Integer disclosed a lowered 2025 sales guidance to a range between $1.840 billion and $1.854 billion and projected poor net and organic sales growth for 2026, causing its stock price to drop more than 32%.
- Investors have until February 9, 2026, to ask the Court to be appointed to lead the case.
- A securities class action lawsuit has been filed against Integer Holdings Corporation (ITGR) and its senior executives by Bleichmar Fonti & Auld LLP, alleging securities fraud.
- The lawsuit claims Integer repeatedly overstated demand for its electrophysiology (EP) devices, despite actual falling demand and revenue.
- Integer's stock price dropped over 32% on October 23, 2025, to $73.89 per share, after the company disclosed lowered 2025 sales guidance and projected poor sales growth for 2026.
- Investors have until February 9, 2026, to seek appointment as lead plaintiff in the case.
- A class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR).
- The lawsuit covers a class period from July 25, 2024, to October 22, 2025, with a lead plaintiff deadline of February 9, 2026.
- The complaint alleges that Integer Holdings materially overstated its competitive position in the EP manufacturing market and experienced a sustained deterioration in sales for two of its EP devices.
- It further claims the company mischaracterized its EP devices as a long-term growth driver for its C&V segment, leading to materially misleading statements about its business and prospects.
- A class action lawsuit has been filed against Integer Holdings Corporation and certain senior executives for securities fraud by Bleichmar Fonti & Auld LLP.
- Investors have until February 9, 2026, to seek appointment as lead plaintiff in the case.
- The lawsuit alleges that Integer repeatedly touted its electrophysiology (EP) sales growth and market position while overstating demand for its EP devices, despite actual sharp declines in demand and revenue.
- The company's stock dropped more than 32% on October 23, 2025, after Integer lowered its 2025 sales guidance and projected poor net and organic sales growth for 2026, attributing it to slower than forecasted adoption of two EP devices.
- Glancy Prongay & Murray LLP reminds investors of the February 9, 2026 deadline to file a lead plaintiff motion in a class action lawsuit against Integer Holdings Corporation (ITGR).
- The lawsuit covers investors who purchased common stock between July 25, 2024, and October 22, 2025 (the Class Period).
- The lawsuit stems from Integer reducing its full-year 2025 sales guidance and anticipating slower growth for 2026, particularly due to slower market adoption and expected decline in sales of new electrophysiology devices, which caused the stock price to fall 32.3% on October 23, 2025.
- Allegations include that Integer materially overstated its competitive position and mischaracterized its electrophysiology devices as a long-term growth driver, despite experiencing a sustained deterioration in sales for two of these devices.
- Grabar Law Office is investigating Integer Holdings Corp. (NYSE: ITGR) for alleged breaches of fiduciary duties by its officers and directors.
- A federal securities fraud class action complaint alleges that ITGR materially overstated its competitive position within the EP manufacturing market and was experiencing sustained deterioration in sales relating to two of its EP devices.
- The complaint further states that ITGR mischaracterized its EP devices as a long-term growth driver for its C&V segment, making positive statements about the company's business, operations, and prospects materially false and misleading.
- Shareholders who purchased ITGR shares prior to July 25, 2024, and still hold them, are encouraged to contact Grabar Law Office for potential corporate reforms and the return of funds.
- A class action lawsuit has been filed against Integer Holdings Corporation (ITGR), with a deadline for lead plaintiff motions set for February 9, 2026.
- The lawsuit covers investors who purchased ITGR common stock between July 25, 2024, and October 22, 2025.
- The complaint alleges that the company made materially false or misleading statements, particularly concerning its competitive position and sales of electrophysiology devices, leading to a reduction in full-year 2025 sales guidance to a range of $1.840 billion to $1.854 billion and projected slower growth for 2026.
- Following the guidance reduction announcement on October 23, 2025, Integer's stock price fell $35.22 per share, or 32.3%, to close at $73.89 per share.
- A class action lawsuit has been filed against Integer Holdings Corporation (ITGR) and its senior executives for securities fraud.
- The lawsuit alleges Integer overstated demand and revenue for its electrophysiology (EP) products, which had actually fallen sharply.
- The company's stock dropped $35.22 per share, or more than 32%, on October 23, 2025, after it lowered its 2025 sales guidance and projected poor net sales growth for 2026.
- Investors have until February 9, 2026, to ask the Court to be appointed to lead the case.
- The Portnoy Law Firm has initiated an investigation into possible securities fraud against Integer Holdings Corporation (NYSE: ITGR).
- The firm may file a class action lawsuit on behalf of investors.
- The filed complaint alleges that Integer materially overstated its competitive position in the electrophysiology manufacturing market and experienced a sustained deterioration in sales for two of its electrophysiology devices.
- It is also alleged that Integer mischaracterized these electrophysiology devices as a long-term growth driver, resulting in false and misleading statements about the company's business, operations, and prospects.
- A class action lawsuit has been filed against Integer Holdings Corporation and certain senior executives for securities fraud by Bleichmar Fonti & Auld LLP.
- The lawsuit alleges Integer overstated demand for its electrophysiology (EP) devices and its EP sales growth, despite actual demand and revenue falling sharply.
- Integer's stock price dropped more than 32% on October 23, 2025, falling from $109.11 to $73.89 per share, after the company lowered its 2025 sales guidance and projected poor net and organic sales growth for 2026 due to slower-than-forecasted adoption of EP devices.
- Investors have until February 9, 2026, to seek appointment as lead plaintiff in the case.
Quarterly earnings call transcripts for Integer Holdings.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more